Relative Bioavailability of CE-Iohexol (Captisol-enabled ™ Iohexol) Injection and Omnipaque™ Injection

Conditions:   Contrast-induced Nephropathy;   Coronary Angiography Interventions:   Other: Omnipaque™ (iohexol) Injection;   Other: CE-Iohexol Sponsors:   CyDex Pharmaceuticals, Inc.;   Ligand Pharmaceuticals;   Syneos Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials